The healthcare world is observing a major shift in glucose therapy with the emergence of GLP-1 skin applications. These patches offer a possibly more convenient alternative to subcutaneous administrations of GLP-1 drugs, reducing the requirement of daily needle pricks. The technology administers the drug directly through the epidermis, arguably boo